# Compiled data

Potential Organism | Accession number |  Drug resistance | Length (bp) | Paper| To use in the analysis
----| ----| ----|----|-----|-----|
*Bordetella hinzii* |[AF177667.1](https://www.ncbi.nlm.nih.gov/nuccore/AF177667)|ampicillin, ampicillin-sulbactam, cefazolin, cefotetan, cefuroxime, ceftriaxone, cefotaxime, aztreonam, chloramphenicol, and ciprofloxacin      |  1522 |  [Application of 16S rRNA Gene Sequencing To Identify Bordetella hinzii as the Causative Agent of Fatal Septicemia](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC86205/) | ✔️
*Bordetella avium* |[AF177666.1](https://www.ncbi.nlm.nih.gov/nuccore/AF177666.1)  |   |  1522 | [Application of 16S rRNA Gene Sequencing To Identify Bordetella hinzii as the Causative Agent of Fatal Septicemia](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC86205/) |✔️
*Neisseria gonorrhea* | [X07714.1](https://www.ncbi.nlm.nih.gov/nuccore/X07714.1/) | Spectinomycin |1544  | [Spectinomycin Resistance in Neisseria spp. Due to Mutations in 16S rRNA](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC89873/) and  [Nucleotide sequence of a 16S ribosomal RNA gene from Neisseria gonorrhoeae.](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC336862/?page=1) | ✔️
*Mycobacterium tuberculosis* |[PRJEB32943](https://www.ncbi.nlm.nih.gov/nuccore/PRJEB32943)|rifampicin, isoniazid, ethambutol, pyrazinamide and streptomycin | 608    | [Molecular characterization of multidrug-resistant Mycobacterium tuberculosis (MDR-TB) isolates identifies local transmission of infection in Kuwait, a country with a low incidence of TB and MDR-TB](https://www.ncbi.nlm.nih.gov/bioproject/PRJEB32943)| ✔️  
*Mycoplasma genitalium* (strain G37) | [X77334.1](https://www.ncbi.nlm.nih.gov/nuccore/X77334)  | Tetracyline |  1490 | [Identification of 16S rRNA mutations in Mycoplasma genitalium potentially associated with tetracycline resistance in vivo but not selected in vitro in M. genitalium and Chlamydia trachomatis](https://pubmed.ncbi.nlm.nih.gov/33537731/) | ✔️
*Pseudomonas aeruginosa* | [LT599799.2](https://www.ncbi.nlm.nih.gov/nuccore/LT599799.2) |    | 1107| unpublished | ✖️
*Pseudomonas aeruginosa* | [ON808422.1](https://www.ncbi.nlm.nih.gov/nuccore/ON808422.1) |    | 622| unpublished | ✖️
*Rauoltella ornithinolytica/*Klebsiella ornithinolytica**|[KT378441.1](https://www.ncbi.nlm.nih.gov/nuccore/KT378441.1) |   |    1404 | unpublished | ✖️
*Salmonella enterica* (subsp. enterica serovar Typhi strain SA14) |[KU843845.1](https://www.ncbi.nlm.nih.gov/nuccore/KU843845)| Cefalotin,Cephalosporin,Cefoxitin, Amikacin, Gentamicin, Tobramycin, Ciprofloxacin, Norfloxacine, Fosphomycin-trometamol| 1002| [Prevalence, serotyping and antimicrobials resistance mechanism of Salmonella enterica isolated from clinical and environmental samples in Saudi Arabia](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5498448/) | ✔️
*Salmonella enterica* (subsp. enterica serovar Paratyphi C strain SA7) | [KU843841.1](https://www.ncbi.nlm.nih.gov/nuccore/KU843841)| Cefalotin,Cephalosporin,Cefoxitin, Amikacin, Gentamicin, Tobramycin, Trimethoprim / sulfamethoxazole| 985 | [Prevalence, serotyping and antimicrobials resistance mechanism of Salmonella enterica isolated from clinical and environmental samples in Saudi Arabia](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5498448/) | ✔️
*Salmonella enterica* (subsp. arizonae strain NS10)|  [KU843866.1](https://www.ncbi.nlm.nih.gov/nuccore/KU843866)|Ampicilin,Cefalotin,Cephalosporin, Ceflodoxime-proxetil, Cefotaxime,Ceftazidime,Ciprofloxacin  |984|[Prevalence, serotyping and antimicrobials resistance mechanism of Salmonella enterica isolated from clinical and environmental samples in Saudi Arabia](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5498448/) | ✔️
*Salmonella enterica* subsp. enterica serovar Paratyphi C strain SA10|[KU843843.1](https://www.ncbi.nlm.nih.gov/nuccore/KU843843.1?report=fasta)|Cefalotin ,Cefuroxime, Cefoxitin, Amikacin,Gentamicin,Tobramycin, Trimethoprim / sulfamethoxazole, cephalosporin |1001 |[Prevalence, serotyping and antimicrobials resistance mechanism of Salmonella enterica isolated from clinical and environmental samples in Saudi Arabia](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5498448/) | ✔️
*Salmonella enterica* (subsp. enterica serovar Paratyphi C strain SA12)|[KU843844.1](https://www.ncbi.nlm.nih.gov/nuccore/KU843844.1?report=fasta)|Cefalotin ,Cefuroxime, Cefoxitin, Amikacin,Gentamicin,Tobramycin, Trimethoprim / sulfamethoxazole, cephalosporin |1003 |[Prevalence, serotyping and antimicrobials resistance mechanism of Salmonella enterica isolated from clinical and environmental samples in Saudi Arabia](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5498448/) | ✔️
*Salmonella enterica* (subsp. enterica serovar Paratyphi B strain CR)|[KU843850.1](https://www.ncbi.nlm.nih.gov/nuccore/KU843850.1?report=fasta)|Cefalotin Ampicilin,Cefalotin,Cephalosporin, Ceflodoxime-proxetil,Cefuroxime, Cefoxitin, Amikacin,Gentamicin,Tobramycin |970 |[Prevalence, serotyping and antimicrobials resistance mechanism of Salmonella enterica isolated from clinical and environmental samples in Saudi Arabia](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5498448/) | ✔️
*Helicobacter pylori* (Strain 108)  |[AY062898.1](https://www.ncbi.nlm.nih.gov/nuccore/AY062898)| Tetracyline | 1496 | [Mutations in the 16S rRNA Genes of Helicobacter pylori Mediate Resistance to Tetracycline](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC134973/) | ✔️
*Helicobacter pylori* (Strain 109) |[AY062899.1](https://www.ncbi.nlm.nih.gov/nuccore/AY062899)| Tetracyline | 1492 | [Mutations in the 16S rRNA Genes of Helicobacter pylori Mediate Resistance to Tetracycline](https://www.ncbi.LN871587.1nlm.nih.gov/pmc/articles/PMC134973/) |✔️
*Staphylococcus aureus* |[MW644614.1](https://www.ncbi.nlm.nih.gov/nuccore/MW644614.1)| Methicillin |   607|  [Phylogenetic relatedness of methicillin-resistant Staphylococcus aureus isolates from the host community and Syrian refugees in Duhok Governorate based on 16S rRNA](https://www.sciencedirect.com/science/article/pii/S2772707622000790) | ✔️
*Acinetobacter baumannii* (strain CWS18)| [FM207520.1](https://www.ncbi.nlm.nih.gov/nuccore/FM207520.1) |  | 735|  [Production of Cell-Cell Signaling Molecules by Bacteria Isolated From Human Chronic Wounds](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2902276/) | ✔️
*Escherichia coli* (isolate A2M11) | [HF564650.1](https://www.ncbi.nlm.nih.gov/nuccore/HF564650.1)|    |   844 | unpublished | ✖️
*Klebsiella pneumoniae* ( strain CWS45) | [FM207545.1](https://www.ncbi.nlm.nih.gov/nuccore/FM207545.1) |     |    679 | [Production of cell-cell signalling molecules by bacteria isolated from human chronic wounds](https://pubmed.ncbi.nlm.nih.gov/19840177/)|✔️
*Streptococcus pneumoniae strain SMSPN* | [MZ749734.1](https://www.ncbi.nlm.nih.gov/nuccore/MZ749734.1) |    |   1048 |[Isolation and Characterization of Drug resistant organisms (unpublished)] | ✖️
*Helicobacter pylori* (isolate MC903) |[U01332.1](https://www.ncbi.nlm.nih.gov/nuccore/U01332.1) |   | 1503 | (published but not accessible)  [A comparison of 16S ribosomal DNA sequences from five isolates of Helicobacter pylori](https://pubmed.ncbi.nlm.nih.gov/8186097/)
*Salmonella typhi* |[Z47544.1](https://www.ncbi.nlm.nih.gov/nuccore/Z47544.1) |     |   1534 | (published but not accessible) [Phylogenetic relationships of Salmonella typhi and Salmonella typhimurium based on 16S rRNA sequence analysis](https://pubmed.ncbi.nlm.nih.gov/9336938/) |  
*Clostridium difficile MD1400* | [MK909925.1](https://www.ncbi.nlm.nih.gov/nuccore/MK909925.1) |Toxin A & B + exposure to ciprofloxacin followed by ceftriaxone, tazocin and gentamicin  | 1,253 | [Diagnostic deficiencies of C. difficile infection among patients in a tertiary hospital in Saudi Arabia: A laboratory-based case series](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8324924/) | ✔️
*Clostridium difficile strain MD1346* | [MK909924.1](https://www.ncbi.nlm.nih.gov/nuccore/MK909924.1) |Toxin A & B + exposure to ciprofloxacin followed by ceftriaxone, tazocin and gentamicin  | 1,209 | [Diagnostic deficiencies of C. difficile infection among patients in a tertiary hospital in Saudi Arabia: A laboratory-based case series](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8324924/) | ✔️
*Clostridium difficile strain MD991* | [MK909923.1](https://www.ncbi.nlm.nih.gov/nuccore/MK909923.1) |Toxin A & B + exposure to ciprofloxacin followed by ceftriaxone, tazocin and gentamicin  | 1,253 | [Diagnostic deficiencies of C. difficile infection among patients in a tertiary hospital in Saudi Arabia: A laboratory-based case series](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8324924/) | ✔️
*Listeria monocytogenes* strain LMEW20|[KY053299.1](https://www.ncbi.nlm.nih.gov/nuccore/KY053299.1?report=fasta)  |   amoxicillin, cloxacillin, augumentin and ceftazidime|1425|[Prevalence of Antibiotics Resistant Listeria monocytogenes Strains in NigerianReady-to-eat Foods](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7004927/)| ✔️
*Listeria monocytogenes* strain LMMP96 |[KY053297.1](https://www.ncbi.nlm.nih.gov/nuccore/KY053297.1?report=fasta)  |   amoxicillin, cloxacillin, augumentin and ceftazidime|1434|[Prevalence of Antibiotics Resistant Listeria monocytogenes Strains in NigerianReady-to-eat Foods](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7004927/)| ✔️
*Acinetobacter ursingii* strain 505| [KM281506.1](https://www.ncbi.nlm.nih.gov/nuccore/KM281506.1?report=fasta)|ceftriaxone, piperacillin and piperacillin tazobactam |1391|[Molecular Methods for Identification of Acinetobacter Species by Partial Sequencing of the rpoB and 16S rRNA Genes](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4572958/)|✔️
*Acinetobacter parvus* strain 227 | [KM281505.1](https://www.ncbi.nlm.nih.gov/nuccore/KM281505.1?report=fasta)|ceftriaxone, piperacillin and piperacillin tazobactam |1391|[Molecular Methods for Identification of Acinetobacter Species by Partial Sequencing of the rpoB and 16S rRNA Genes](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4572958/)|✔️
*Acinetobacter schindleri* strain 24| [KM281503.1](https://www.ncbi.nlm.nih.gov/nuccore/KM281503.1?report=fasta)|ceftriaxone, piperacillin and piperacillin tazobactam |1393|[Molecular Methods for Identification of Acinetobacter Species by Partial Sequencing of the rpoB and 16S rRNA Genes](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4572958/)|✔️
*Acinetobacter baumannii* strain 313| [KM281496.1](https://www.ncbi.nlm.nih.gov/nuccore/KM281496.1?report=fasta)|ceftriaxone, piperacillin and piperacillin tazobactam |1391|[Molecular Methods for Identification of Acinetobacter Species by Partial Sequencing of the rpoB and 16S rRNA Genes](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4572958/)|✔️
*Acinetobacter johnsonii* strain 476| [KM281498.1](https://www.ncbi.nlm.nih.gov/nuccore/KM281498.1?report=fasta)|ceftriaxone, piperacillin and piperacillin tazobactam |1392|[Molecular Methods for Identification of Acinetobacter Species by Partial Sequencing of the rpoB and 16S rRNA Genes](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4572958/)|✔️
*Acinetobacter calcoaceticus* strain 364| [KM281495.1](https://www.ncbi.nlm.nih.gov/nuccore/KM281495.1?report=fasta)|ceftriaxone, piperacillin and piperacillin tazobactam |1392|[Molecular Methods for Identification of Acinetobacter Species by Partial Sequencing of the rpoB and 16S rRNA Genes](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4572958/)|✔️
